Why Massachusetts is the State of Possible – From the Speakers of MassBio’s Annual Meeting

Mar 12, 2019

We asked the speakers of MassBio’s Annual Meeting, now the State of Possible Conference, why they think Massachusetts is the State of Possible. Here’s what they said:

“Over 800 biotech, pharma and medical device companies in Massachusetts. 45 Boston institutions receive $2 billion in NIH awards — largest for any city for two decades. Amazing student entrepreneurs aided by dedicated investors and philanthropists — Wyss, Blavatnik, Broad, Koch, Whitehead, Paulson, Ragon…”

  • George Church Phd, Professor of Genetics, Harvard Medical School

“Massachusetts is the center of the world’s leading life sciences cluster, bringing cutting-edge innovation to patients around the world. There’s no better place to see the convergence of science, medicine, and business.”

  • John Maraganore, Chief Executive Officer, Alnylam

“From Henry David Thoreau and Louisa May Alcott to Elizabeth Warren and Phil Sharp, Massachusetts has always been home to intellectual iconoclasts. Never settling for the world as it is and applying the hard work of deep thinking to try to make it better. Put those two things together and you have… the State of Possible.”

  • Katrine Bosley, former Chief Executive Officer, Editas Medicine

“For more than a quarter of a century, both the private and public sectors of Massachusetts have worked diligently to support the rapidly growing life sciences industry through collaboration and coordination which has fostered innovation and sustainable opportunities. This has enabled Massachusetts to become the global hub for the life science industry.”

  • Leslie Williams, Director, Founder, President and CEO, ImmusanT

“Over the past few years, you can’t turn a corner in Boston, Cambridge and even further out without seeing the vast growth in business, as evidenced by mass construction and the emergence of both new and more familiar healthcare companies. As the nation’s fastest growing city in biotech, Boston–and by extension–Massachusetts is now home to 20 of the leading global drug companies as well as all the top medical device companies.  Our major academic powerhouses and research are unrivaled, helping the state to attract incredible talent and providing over 100,000 jobs in biotech alone. In the Bay State, anything is possible.”

  • Paula Ragan, CEO, X4Pharmaceuticals

“Fierce curiosity, deep passion and unwavering commitment in the pursuit of advancing science that will change the lives of patients is what makes Massachusetts the State of Possible.”

  • Kerry Wentworth, Chief Regulatory Officer, Flexion Therapeutics


To hear directly from these speakers, and to celebrate Massachusetts as the State of Possible, register for our Annual Meeting today!

See all MassBio News